細胞凍結保存の市場規模、シェア、成長分析：製品別、用途別、最終用途別、地域別 - 産業予測 2025年～2032年

細胞凍結保存市場規模は2023年に88億米ドルと評価され、2024年の107億8,000万米ドルから2032年には546億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは22.5%で成長する見通しです。

細胞凍結保存は、細胞を極低温で浮遊状態に維持し、氷結晶の形成を防ぎながら生存能力を効果的に保持する能力で人気を集めています。この技術は、基礎研究と医療応用の両方で使用される幹細胞や生存組織を含む生物学的材料を保存するために不可欠です。従来の凍結法では、膜の損傷や浸透圧ショックにより細胞が死滅することが多く、長期保存には凍結保存が不可欠です。最近の凍結保護剤と温度制御技術の進歩により、凍結保存の成功率は著しく向上しています。さらに、凍結保存された細胞や組織の広範な品質検査により、移植への適合性評価が可能になり、新鮮なサンプルの必要性がなくなり、研究や治療の機会が向上しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

細胞凍結保存市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 細胞凍結培地
  • エチレングリコール
  • ジメチルスルホキシド
  • グリセロール
  • その他
• 装置
  • 冷凍庫
  • インキュベーター
  • 液体窒素供給タンク
• 消耗品
  • 極低温バイアル
  • 極低温チューブ
  • クーラーボックス/コンテナ
  • その他

細胞凍結保存市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 幹細胞
• 卵母細胞と胚細胞
• 精子細胞
• 肝細胞
• その他

細胞凍結保存市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• バイオ医薬品および製薬会社
• 調査機関
• バイオバンク
• 体外受精クリニック
• その他

細胞凍結保存市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific（US）
• Merck KGaA（Germany）
• GE Healthcare（US）
• BioLife Solutions, Inc.（US）
• Cook Medical（US）
• FUJIFILM Irvine Scientific（US）
• Lonza（Switzerland）
• Sartorius AG（Germany）
• Cytiva（US）
• Corning Incorporated（US）
• STEMCELL Technologies Inc.（Canada）
• PromoCell GmbH（Germany）
• Bio-Techne Corporation（US）
• HiMedia Laboratories Pvt. Ltd.（India）
• Miltenyi Biotec（Germany）
• Takara Bio Inc.（Japan）
• ReproCELL Inc.（Japan）
• Core Dynamics, LLC（US）
• Chart Industries, Inc.（US）
• Worthington Industries（US）

結論と推奨事項

Cell Cryopreservation Market size was valued at USD 8.8 billion in 2023 and is poised to grow from USD 10.78 billion in 2024 to USD 54.66 billion by 2032, growing at a CAGR of 22.5% during the forecast period (2025-2032).

Cell cryopreservation is gaining traction for its ability to maintain cells in a suspended state at cryogenic temperatures, effectively preserving their viability while preventing ice crystal formation. This technique is essential for preserving biological materials, including stem cells and viable tissues, used in both basic research and medical applications. Traditional freezing methods often lead to cell death due to membrane damage and osmotic shock, making cryopreservation vital for long-term storage. Recent advancements in cryoprotective agents and temperature control technologies have significantly improved the success rates of cryopreservation. Furthermore, extensive quality testing of cryopreserved cells and tissues allows for their suitability assessment for transplantation, eliminating the need for fresh samples and enhancing research and therapeutic opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Cryopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Cryopreservation Market Segments Analysis

Global Cell Cryopreservation Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cell Freezing Media, Equipment and Consumables. Based on Application, the market is segmented into Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes and Others. Based on End Use, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobanks, IVF clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Cryopreservation Market

The global cell cryopreservation market is projected to experience significant growth driven by the escalating prevalence of chronic diseases and the emergence of novel viruses. This trend is further propelled by the heightened research and development efforts in stem cell science, as scientists and clinicians delve deeper into this field. Educational institutions worldwide are offering grants to PhD students, Clinical Research Fellows, and postdoctoral researchers, thereby fostering advancements in stem cell research. Additionally, various government initiatives aimed at promoting research activities within the pharmaceutical and biopharmaceutical sectors are also contributing to the market's expansion, highlighting the increasing importance of cell preservation technologies.

Restraints in the Cell Cryopreservation Market

The cell cryopreservation market faces significant restraints due to the presence of alternative therapies and the substantial costs associated with storage solutions. As various treatment options gain popularity, the demand for traditional cryopreservation methods may be impacted negatively. Additionally, the high expenses involved in maintaining and operating storage facilities for cryopreserved cells further hinder market growth. These financial burdens can deter new entrants and existing businesses from expanding their offerings, ultimately limiting the potential expansion of the cell cryopreservation market in the face of competing technologies and solutions that provide similar benefits at potentially reduced costs.

Market Trends of the Cell Cryopreservation Market

The cell cryopreservation market is increasingly favoring vitrification as a dominant preservation technique, driven by advancements in cryobiology and cell storage technologies. This method leverages fast freezing using high concentrations of cryoprotectants, significantly reducing ice formation and cellular damage compared to traditional slow cooling processes. While vitrification enhances cell viability and recovery rates, concerns about potential toxicity from concentrated cryoprotectants highlight the need for ongoing research and optimization. As the demand for cell-based therapies and regenerative medicine rises, the market is witnessing innovation and investment focused on improving vitrification techniques to enhance safety and efficacy in cryopreservation applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Cell Cryopreservation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cell Freezing Media
  • Ethylene Glycol
  • Dimethyl Sulfoxide
  • Glycerol
  • Others
• Equipment
  • Freezers
  • Incubators
  • Liquid Nitrogen Supply Tanks
• Consumables
  • Cryogenic vials
  • Cryogenic tubes
  • Cooler boxes/containers
  • Others

Global Cell Cryopreservation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Stem Cells
• Oocytes and Embryotic cells
• Sperm Cells
• Hepatocytes
• Others

Global Cell Cryopreservation Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical & Pharmaceutical Companies
• Research Institutes
• Biobanks
• IVF clinics
• Others

Global Cell Cryopreservation Market Size & CAGR (2025-2032)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReproCELL Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Core Dynamics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chart Industries, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worthington Industries (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations